insights_auto
Istiqbol: 64.5% optimistik·3.2% pessimistik
Tahlilga kirishchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,48 US$
arrow_upward
+1,72%(+0,025) 1K
1,43 US$
arrow_downward
-3,05% (-0,045)todayBirjadan oldin
Savdolar yopilgan: 11-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINO tikeri uchun statistika yaratilmoqda...
Ochish
1,37 US$
Yuqori
1,48 US$
Past
1,30 US$
Bozor kapitali
249,17 mln
Oʻrtacha hajm
18,79 mln
Hajmi
79,31 ming
52 haftalik eng yuqori
2,72 US$
52 haftalik eng past
0,57 US$
Aksiya boʻyicha daromad
-1,17 US$
Beta
1,71
Muomaladagi aksiyalar
103,40 mln
Xodimlar soni
112
Ochish
1,37 US$
Yuqori
1,48 US$
Past
1,30 US$
Bozor kapitali
249,17 mln
Oʻrtacha hajm
18,79 mln
Hajmi
79,31 ming
52 haftalik eng yuqori
2,72 US$
52 haftalik eng past
0,57 US$
Aksiya boʻyicha daromad
-1,17 US$
Beta
1,71
Muomaladagi aksiyalar
103,40 mln
Xodimlar soni
112
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
GuruFocus
·
20 soat oldin
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
1 kun oldin
Inovio Pharmaceuticals Q3 Earnings Call Highlights
TradingView
·
1 kun oldin
Inovio Pharmaceuticals Q3 2026 Earnings Call Is Live
Yahoo Finance
·
1 kun oldin
INOVIO Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals Inc haqida
CEOJacqueline Shea
Xodimlar soni112
Asos solingan1999
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytinovio.com